New Nanopackaging for Chemo Agents for Targeted Killing of Tumors
We report for the first time on a nano-drug delivery system based on glucosylated polymeric nanomicelles to actively target the second-generation tyrosine kinase inhibitor dasatinib to glucose-avid pediatric sarcomas by the intravenous route. Afte...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Nanomedicine Oncology Source Type: blogs
More News: Cancer & Oncology | Chemotherapy | Children | Hospitals | Israel Health | Medical Devices | Middle East Health | Nanotechnology | Pediatrics | Rhabdomyosarcoma | Sarcomas | Study